Chemoinformaics analysis of Diallyltrisulfide (DTS)
| Molecular Weight | 178.347 | nRot | 6 |
| Heavy Atom Molecular Weight | 168.267 | nRig | 2 |
| Exact Molecular Weight | 177.994 | nRing | 0 |
| Solubility: LogS | -4.408 | nHRing | 0 |
| Solubility: LogP | 2.302 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 25.3879 |
| nHD | 0 | BPOL | 12.4921 |
| QED | 0.348 |
| Synth | 3.972 |
| Natural Product Likeliness | 1.203 |
| NR-PPAR-gamma | 0.078 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.085 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.561 |
| MDCK | 0.0000247 |
| BBB | 0.954 |
| PPB | 0.753345 |
| VDSS | 0.977 |
| FU | 0.0425128 |
| CYP1A2-inh | 0.899 |
| CYP1A2-sub | 0.887 |
| CYP2c19-inh | 0.975 |
| CYP2c19-sub | 0.834 |
| CYP2c9-inh | 0.884 |
| CYP2c9-sub | 0.888 |
| CYP2d6-inh | 0.502 |
| CYP2d6-sub | 0.906 |
| CYP3a4-inh | 0.694 |
| CYP3a4-sub | 0.4 |
| CL | 11.88 |
| T12 | 0.237 |
| hERG | 0.02 |
| Ames | 0.89 |
| ROA | 0.581 |
| SkinSen | 0.964 |
| Carcinogencity | 0.584 |
| EI | 0.995 |
| Respiratory | 0.962 |
| NR-Aromatase | 0.025 |
| Antiviral | No |
| Prediction | 0.972242 |